Oxford Asset Management’s CVS Health CVS Stock Holding History

Oxford Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,999	Closed	-$808K	–	526
2024 Q4	$808K	Buy	17,999 +9,443	+110%	+$530K	0.36%	71
2024 Q3	$538K	Buy	+8,556	New	+$499K	0.45%	65
2019 Q3	–	Sell	-69,042	Closed	-$3.76M	–	1759
2019 Q2	$3.76M	Sell	69,042 -74,102	-52%	-$3.99M	0.08%	361
2019 Q1	$7.72M	Buy	143,144 +90,929	+174%	+$5.61M	0.17%	137
2018 Q4	$3.42M	Buy	+52,215	New	+$3.9M	0.09%	248
2018 Q1	–	Sell	-4,312	Closed	-$314K	–	1660
2017 Q4	$314K	Sell	4,312 -114,165	-96%	-$8.3M	0.01%	1322
2017 Q3	$9.62M	Sell	118,477 -4,092	-3%	-$324K	0.19%	75
2017 Q2	$9.86M	Buy	122,569 +71,671	+141%	+$5.66M	0.2%	77
2017 Q1	$4M	Buy	+50,898	New	+$4.06M	0.1%	199

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Oxford Asset Management's CVS Position: Q1 2025 in Review

Oxford Asset Management sold out of CVS Health (CVS) in Q1 2025, closing a stake of 17,999 shares — an estimated $808K sold.

Oxford Asset Management first reported a position in CVS in Q1 2017 and held it in 9 quarters. The position peaked at $9.86M in Q2 2017. 1,757 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

Oxford Asset Management reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
Oxford Asset Management sold 17,999 CVS Health shares in Q1 2025, an estimated $808K.
Oxford Asset Management first reported a position in CVS Health in Q1 2017 and held it in 9 quarters.
Oxford Asset Management's CVS Health position peaked at $9.86M in Q2 2017.
1,757 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.